Imran Haque

Dr Imran Haque, SVP of AI and Digital Sciences at Recursion Pharmaceuticals, discusses why AI drug discovery is challenging, the need for better understanding of drug interactions, the trade-offs in translational models, advancements in computational modeling and data acquisition in biology, and the value of being a generalist in the field.